SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Livia Rossi, Alejandro Escobar-Gutierrez, Paula Rahal, Advanced Molecular Surveillance of Hepatitis C Virus, Viruses, 2015, 7, 3, 1153

    CrossRef

  2. 2
    Chunhua Li, Eleanor Barnes, Paul N. Newton, Yongshui Fu, Manivanh Vongsouvath, Paul Klenerman, Hiroaki Okamoto, Kenji Abe, Oliver G. Pybus, Ling Lu, An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes, Virology, 2015, 476, 355

    CrossRef

  3. 3
    Sheng-Shun Yang, Jia-Horng Kao, Asunaprevir-containing regimens for the treatment of hepatitis C virus infection, Expert Review of Gastroenterology & Hepatology, 2015, 9, 1, 9

    CrossRef

  4. 4
    Federico Alejandro Di Lello, Adrián Alejandro Farias, Andrés Carlos Alberto Culasso, Paula Soledad Pérez, María Belén Pisano, Marta Silvia Contigiani, Rodolfo Héctor Campos, Viviana Elizabeth Ré, Changing epidemiology of hepatitis C virus genotypes in the central region of Argentina, Archives of Virology, 2015, 160, 4, 909

    CrossRef

  5. 5
    Charlotte Hedskog, Brian Doehle, Krishna Chodavarapu, Viktoria Gontcharova, Javier Crespo Garcia, Robert De Knegt, Joost P.H Drenth, John G. McHutchison, Diana Brainard, Luisa M. Stamm, Michael D. Miller, Evguenia Svarovskaia, Hongmei Mo, Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin, Hepatology, 2015, 61, 2
  6. 6
    Allah Nawaz, Syed Faisal Zaidi, Khan Usmanghani, Irshad Ahmad, Concise review on the insight of hepatitis C, Journal of Taibah University Medical Sciences, 2015,

    CrossRef

  7. 7
    Donald Jensen, Kenneth E Sherman, Christophe Hézode, Stanislas Pol, Stefan Zeuzem, Victor de Ledinghen, Albert Tran, Magdy Elkhashab, Ziad H Younes, Marcelo Kugelmas, Stefan Mauss, Gregory Everson, Velimir Luketic, John Vierling, Lawrence Serfaty, Maurizia Brunetto, Jeong Heo, David Bernstein, Fiona McPhee, Delphine Hennicken, Patricia Mendez, Eric Hughes, Stephanie Noviello, Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders, Journal of Hepatology, 2015,

    CrossRef

  8. 8
    Barbara Bartolini, Raffaella Lionetti, Emanuela Giombini, Catia Sias, Chiara Taibi, Marzia Montalbano, D’Offizi Gianpiero, Fiona McPhee, Eric A. Hughes, Nannan Zhou, Giuseppe Ippolito, Anna Rosa Garbuglia, Maria R. Capobianchi, Dynamics of HCV genotype 4 resistance-associated variants during virologic escape with pIFN/RBV+daclatasvir: A case study using ultra deep pyrosequencing, Journal of Clinical Virology, 2015, 66, 38

    CrossRef

  9. 9
    Yi-Ping Li, Santseharay Ramirez, Lotte Mikkelsen, Jens Bukh, M. S. Diamond, Efficient Infectious Cell Culture Systems of the Hepatitis C Virus (HCV) Prototype Strains HCV-1 and H77, Journal of Virology, 2015, 89, 1, 811

    CrossRef

  10. 10
    M. W. Robinson, R. Swann, A. Sigruener, S. T. Barclay, P. R. Mills, J. McLauchlan, A. H. Patel, Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus, Journal of Viral Hepatitis, 2015, 22, 4
  11. 11
    M. Castells, G. Bello, S. Ifrán, S. Pereyra, S. Boschi, R. Uriarte, J. Cristina, R. Colina, Epidemic history of major genotypes of hepatitis C virus in Uruguay, Infection, Genetics and Evolution, 2015, 32, 231

    CrossRef

  12. 12
    Eric Lawitz, Greg Sullivan, Maribel Rodriguez-Torres, Michael Bennett, Fred Poordad, Mudra Kapoor, Prajakta Badri, Andrew Campbell, Lino Rodrigues, Yiran Hu, Tami Pilot-Matias, Regis A. Vilchez, Exploratory trial of ombitasvir and ABT-450/r with or without ribavirin for HCV genotype 1, 2, and 3 infection, Journal of Infection, 2015, 70, 2, 197

    CrossRef

  13. 13
    E.C.M. Cunha, M.F. Behrensdorf, V. Bavaresco, D.N. Zambrano, J. Bellini, M.P. Kaster, B. Spessato, G. Ghisleni, Genotype 1 of hepatitis C virus increases the risk of major depression: a 12-week prospective study, General Hospital Psychiatry, 2015,

    CrossRef

  14. 14
    Monoj Mon Kalita, Stephen Griffin, James J. Chou, Wolfgang B. Fischer, Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2015, 1848, 6, 1383

    CrossRef

  15. You have free access to this content15
    Jane P. Messina, Isla Humphreys, Abraham Flaxman, Anthony Brown, Graham S. Cooke, Oliver G. Pybus, Eleanor Barnes, Global distribution and prevalence of hepatitis C virus genotypes, Hepatology, 2015, 61, 1
  16. 16
    Maria Buti, Rafael Esteban, Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’, Expert Review of Gastroenterology & Hepatology, 2015, 9, 3, 375

    CrossRef

  17. 17
    Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, Maria Buti, Antonio Madejon, Sofia Perez-del-Pulgar, Damir Garcia-Cehic, Rosario Casillas, Maria Blasi, Maria Homs, David Tabernero, Miguel Alvarez-Tejado, Jose Manuel Muñoz, Maria Cubero, Andrea Caballero, Jose Antonio delCampo, Esteban Domingo, Irene Belmonte, Leonardo Nieto, Sabela Lens, Paloma Muñoz-de-Rueda, Paloma Sanz-Cameno, Silvia Sauleda, Marta Bes, Jordi Gomez, Carlos Briones, Celia Perales, Julie Sheldon, Lluis Castells, Lluis Viladomiu, Javier Salmeron, Angela Ruiz-Extremera, Rosa Quiles-Pérez, Ricardo Moreno-Otero, Rosario López-Rodríguez, Helena Allende, Manuel Romero-Gómez, Jaume Guardia, Rafael Esteban, Javier Garcia-Samaniego, Xavier Forns, Juan Ignacio Esteban, Y.-W. Tang, High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods, Journal of Clinical Microbiology, 2015, 53, 1, 219

    CrossRef

  18. 18
    Mohammed Eslam, Jacob George, Is hepatitis C subtyping still relevant in the era of direct-acting antiviral therapy?, Hepatology International, 2015, 9, 1, 5

    CrossRef

  19. 19
    Evan B. Cunningham, Tanya L. Applegate, Andrew R. Lloyd, Gregory J. Dore, Jason Grebely, Mixed HCV infection and reinfection in people who inject drugs—impact on therapy, Nature Reviews Gastroenterology & Hepatology, 2015, 12, 4, 218

    CrossRef

  20. 20
    Graham R. Foster, Mutant Ninja viruses, Hepatology, 2015, 61, 2
  21. 21
    J. R. Brister, D. Ako-adjei, Y. Bao, O. Blinkova, NCBI Viral Genomes Resource, Nucleic Acids Research, 2015, 43, D1, D571

    CrossRef

  22. 22
    Christophe Hézode, Tarik Asselah, K Rajender Reddy, Tarek Hassanein, Marina Berenguer, Katarzyna Fleischer-Stepniewska, Patrick Marcellin, Coleen Hall, Gretja Schnell, Tami Pilot-Matias, Niloufar Mobashery, Rebecca Redman, Regis A Vilchez, Stanislas Pol, Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial, The Lancet, 2015,

    CrossRef

  23. 23
    Steven De Keukeleire, Patrick Descheemaeker, Marijke Reynders, Potential risk of misclassification HCV 2k/1b strains as HCV 2a/2c using VERSANT HCV Genotype 2.0 Assay, Diagnostic Microbiology and Infectious Disease, 2015,

    CrossRef

  24. 24
    Troels K.H. Scheel, Peter Simmonds, Amit Kapoor, Surveying the global virome: Identification and characterization of HCV-related animal hepaciviruses, Antiviral Research, 2015, 115, 83

    CrossRef

  25. 25
    Lauren Holz, Barbara Rehermann, T cell responses in hepatitis C virus infection: Historical overview and goals for future research, Antiviral Research, 2015, 114, 96

    CrossRef

  26. 26
    Ling Lu, Yan Xu, Jie Yuan, Chunhua Li, Donald G. Murphy, The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages, Virology, 2015, 482, 111

    CrossRef

  27. 27
    Cristina del Barrio Gascón, Maria Buti, The potential role of simeprevir for the treatment of hepatitis C, Future Virology, 2015, 10, 2, 67

    CrossRef

  28. 28
    Neil Arvin Bretaña, Lies Boelen, Rowena Bull, Suzy Teutsch, Peter A. White, Andrew R. Lloyd, Fabio Luciani, Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012, Emerging Infectious Diseases, 2015, 21, 5, 765

    CrossRef

  29. 29
    Jessica Cusato, Sarah Allegra, Lucio Boglione, Amedeo De Nicolò, Giuseppe Cariti, Giovanni Di Perri, Antonio D’Avolio, VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy, Pharmacogenetics and Genomics, 2015, 25, 4, 164

    CrossRef

  30. 30
    Mark W. Robinson, Elihu Aranday-Cortes, Derek Gatherer, Rachael Swann, Jolanda M. P. Liefhebber, Ana Da Silva Filipe, Alex Sigruener, Stephen T. Barclay, Peter R. Mills, Arvind H. Patel, John McLauchlan, Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection, Liver International, 2015, 35, 5
  31. 31
    E. Rodríguez de Santiago, J. Martínez González, F. Gea Rodríguez, A. Albillos Martínez, Actualización en el tratamiento de la hepatitis C, Medicine - Programa de Formación Médica Continuada Acreditado, 2014, 11, 69, 4103

    CrossRef

  32. 32
    Myrna Adianti, Chie Aoki, Mari Komoto, Lin Deng, Ikuo Shoji, Tutik Sri Wahyuni, Maria Inge Lusida, Soetjipto, Hiroyuki Fuchino, Nobuo Kawahara, Hak Hotta, Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species, Microbiology and Immunology, 2014, 58, 3
  33. 33
    Thomas H.R. Carlsen, Jannie Pedersen, Jannick C. Prentoe, Erick Giang, Zhen-Yong Keck, Lotte S. Mikkelsen, Mansun Law, Steven K.H. Foung, Jens Bukh, Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a, Hepatology, 2014, 60, 5
  34. 34
    D. Struck, G. Lawyer, A.-M. Ternes, J.-C. Schmit, D. P. Bercoff, COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification, Nucleic Acids Research, 2014, 42, 18, e144

    CrossRef

  35. 35
    D. B. Smith, P. Simmonds, S. Jameel, S. U. Emerson, T. J. Harrison, X.-J. Meng, H. Okamoto, W. H. M. Van der Poel, M. A. Purdy, Consensus proposals for classification of the family Hepeviridae, Journal of General Virology, 2014, 95, Pt_10, 2223

    CrossRef

  36. 36
    Yuling An, Tao Wu, Min Wang, Ling Lu, Chunhua Li, Yuanpin Zhou, Yongshui Fu, Guihua Chen, Conservation in China of a novel group of HCV variants dating to six centuries ago, Virology, 2014, 464-465, 21

    CrossRef

  37. 37
    Miguel E. Quiñones-Mateu, Santiago Avila, Gustavo Reyes-Teran, Miguel A. Martinez, Deep sequencing: Becoming a critical tool in clinical virology, Journal of Clinical Virology, 2014, 61, 1, 9

    CrossRef

  38. 38
    Sulyi Kim, Tomoko Date, Hiroshi Yokokawa, Tamaki Kono, Hideki Aizaki, Patrick Maurel, Claire Gondeau, Takaji Wakita, Development of hepatitis C virus genotype 3a cell culture system, Hepatology, 2014, 60, 6
  39. 39
    EASL Clinical Practice Guidelines: Management of hepatitis C virus infection, Journal of Hepatology, 2014, 60, 2, 392

    CrossRef

  40. 40
    Mun-Teng Wong, Steve S-L Chen, Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection, Cellular and Molecular Immunology, 2014,

    CrossRef

  41. 41
    L. Lu, C. Li, Y. Xu, D. G. Murphy, Full-length genomes of 16 hepatitis C virus genotype 1 isolates representing subtypes 1c, 1d, 1e, 1g, 1h, 1i, 1j and 1k, and two new subtypes 1m and 1n, and four unclassified variants reveal ancestral relationships among subtypes, Journal of General Virology, 2014, 95, Pt_7, 1479

    CrossRef

  42. 42
    Irshad ur Rehman, Gilberto Vaughan, Michael A. Purdy, Guo-liang Xia, Joseph C. Forbi, Livia Maria Gonçalves Rossi, Sadia Butt, Muhammad Idrees, Yury E. Khudyakov, Genetic history of hepatitis C virus in Pakistan, Infection, Genetics and Evolution, 2014, 27, 318

    CrossRef

  43. 43
    Sreedhar Chinnaswamy, Genetic Variants at theIFNL3Locus and Their Association with Hepatitis C Virus Infections Reveal Novel Insights into Host-Virus Interactions, Journal of Interferon & Cytokine Research, 2014, 34, 7, 479

    CrossRef

  44. 44
    Juliana Chan, Hepatitis C, Disease-a-Month, 2014, 60, 5, 201

    CrossRef

  45. 45
    Imran Shahid, Waleed Hassan ALMalki, Muhammad Hassan Hafeez, Sajida Hassan, Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies, Critical Reviews in Microbiology, 2014, 1

    CrossRef

  46. 46
    Sarah Aherfi, Caroline Solas, Anne Motte, Jacques Moreau, Patrick Borentain, Saadia Mokhtari, Danielle Botta-Fridlund, Catherine Dhiver, Isabelle Portal, Jean-Marie Ruiz, Isabelle Ravaux, Sylvie Bregigeon, Isabelle Poizot-Martin, Andreas Stein, René Gérolami, Philippe Brouqui, Catherine Tamalet, Philippe Colson, Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France, Journal of Medical Virology, 2014, 86, 11
  47. 47
    Zhi Hong, Xiaojie Yang, Guangbo Yang, Leiliang Zhang, Hepatitis C virus NS5A competes with PI4KB for binding to ACBD3 in a genotype-dependent manner, Antiviral Research, 2014, 107, 50

    CrossRef

  48. 48
    E. T. Chivero, N. Bhattarai, R. T. Rydze, M. A. Winters, M. Holodniy, J. T. Stapleton, Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro, Journal of General Virology, 2014, 95, Pt_6, 1307

    CrossRef

  49. 49
    Manish Chandra Choudhary, Vidhya Natarajan, Priyanka Pandey, Ekta Gupta, Shvetank Sharma, Rachana Tripathi, M. Shesheer Kumar, Syed N. Kazim, Shiv K. Sarin, Identification of Indian sub-continent as hotspot for HCV genotype 3a origin by Bayesian evolutionary reconstruction, Infection, Genetics and Evolution, 2014, 28, 87

    CrossRef

  50. 50
    Xia Rong, Ru Xu, Huaping Xiong, Min Wang, Ke Huang, Qiuyu Chen, Chengyao Li, Qiao Liao, Jieting Huang, Wenjie Xia, Guangping Luo, Xin Ye, Ming Zhang, Yongshui Fu, Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011, Archives of Virology, 2014, 159, 12, 3231

    CrossRef

  51. 51
    Mina John, Silvana Gaudieri, Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines, Frontiers in Microbiology, 2014, 5,

    CrossRef

  52. 52
    E. S. Svarovskaia, H. Dvory-Sobol, N. Parkin, C. Hebner, V. Gontcharova, R. Martin, W. Ouyang, B. Han, S. Xu, K. Ku, S. Chiu, E. Gane, I. M. Jacobson, D. R. Nelson, E. Lawitz, D. L. Wyles, N. Bekele, D. Brainard, W. T. Symonds, J. G. McHutchison, M. D. Miller, H. Mo, Infrequent Development of Resistance in Genotype 1-6 Hepatitis C Virus-Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials, Clinical Infectious Diseases, 2014, 59, 12, 1666

    CrossRef

  53. 53
    Stephen M. Laidlaw, Lynn B. Dustin, Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCV, Frontiers in Immunology, 2014, 5,

    CrossRef

  54. 54
    Cordelia Manickam, R. Keith Reeves, Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections, Frontiers in Microbiology, 2014, 5,

    CrossRef

  55. 55
    Asghar Ashrafi Hafez, Rasoul Baharlou, Seyed Dawood Mousavi Nasab, Abbas Ahmadi Vasmehjani, Mohammad Shayestehpour, Negar Joharinia, Nayeb Ali Ahmadi, Molecular Epidemiology of Different Hepatitis C Genotypes in Serum and Peripheral Blood Mononuclear Cells in Jahrom City of Iran, Hepatitis Monthly, 2014, 14, 4

    CrossRef

  56. 56
    Stephanie Pfaender, Richard JP Brown, Thomas Pietschmann, Eike Steinmann, Natural reservoirs for homologs of hepatitis C virus, Emerging Microbes & Infections, 2014, 3, 3, e21

    CrossRef

  57. 57
    M. Cornberg, C. Höner zu Siederdissen, B. Maasoumy, M.P. Manns, Neue direkt antivirale Medikamente zur Behandlung der chronischen Hepatitis C 2014, Der Internist, 2014, 55, 4, 390

    CrossRef

  58. 58
    Jean–Michel Pawlotsky, New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges, Gastroenterology, 2014, 146, 5, 1176

    CrossRef

  59. 59
    Chunhua Li, Van H. Pham, Kenji Abe, Ling Lu, Nine additional complete genome sequences of HCV genotype 6 from Vietnam including new subtypes 6xb and 6xc, Virology, 2014, 468-470, 172

    CrossRef

  60. 60
    Guido Stirnimann, Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C, Expert Opinion on Pharmacotherapy, 2014, 15, 17, 2609

    CrossRef

  61. 61
    Eleonora Grassi, Alessio Aghemo, Massimo Colombo, Optimal Management of Hepatitis C Genotype 2 Chronic Infection, Current Hepatology Reports, 2014, 13, 4, 273

    CrossRef

  62. 62
    C. Li, L. Lu, D. G. Murphy, F. Negro, H. Okamoto, Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e, Journal of General Virology, 2014, 95, Pt_8, 1677

    CrossRef

  63. 63
    James C. Iles, Jayna Raghwani, G.L. Abby Harrison, Jacques Pepin, Cyrille F. Djoko, Ubald Tamoufe, Matthew LeBreton, Bradley S. Schneider, Joseph N. Fair, Felix M. Tshala, Patrick K. Kayembe, Jean Jacques Muyembe, Samuel Edidi-Basepeo, Nathan D. Wolfe, Peter Simmonds, Paul Klenerman, Oliver G. Pybus, Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa, Virology, 2014, 464-465, 233

    CrossRef

  64. 64
    Mazaher Khodabandehloo, Daem Roshani, Prevalence of Hepatitis C Virus Genotypes in Iranian Patients: a Systematic Review and Meta-Analysis, Hepatitis Monthly, 2014, 14, 11

    CrossRef

  65. 65
    Mohamed S. Abdel-Hakeem, Naglaa H. Shoukry, Protective Immunity Against Hepatitis C: Many Shades of Gray, Frontiers in Immunology, 2014, 5,

    CrossRef

  66. 66
    C Ramière, P Tremeaux, A Caporossi, M Trabaud, F Lebossé, F Bailly, M Thélu, J Nana, V Leroy, P Morand, P André, P André, S Larrat, Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment, Eurosurveillance, 2014, 19, 43, 20944

    CrossRef

  67. 67
    Zhen Yang, Yongxin Yu, Hongzhong Zhang, Guifang Shang, Jialiang Gao, Jian-Dong Jiang, Zonggen Peng, Replication priority of hepatitis C virus genotype 2a in a Chinese cohort, Acta Pharmaceutica Sinica B, 2014, 4, 4, 266

    CrossRef

  68. 68
    Abdolreza Esmaeilzadeh, Maryam Erfanmanesh, Sousan Ghasemi, Farzaneh Mohammadi, Serological Assay and Genotyping of Hepatitis C Virus in Infected Patients in Zanjan Province, Hepatitis Monthly, 2014, 14, 9

    CrossRef

  69. 69
    Christoph Höner zu Siederdissen, Markus Cornberg, Sofosbuvir for the treatment of patients with genotype 2 or 3 chronic hepatitis C virus infection, Clinical Investigation, 2014, 4, 4, 361

    CrossRef

  70. 70
    Bryant B. Summers, Joshua W. F. Beavers, Olga M. Klibanov, Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus, Journal of Pharmacy and Pharmacology, 2014, 66, 12
  71. 71
    Andrés Carlos Alberto Culasso, Adrián Farías, Federico Alejandro Di Lello, Marcelo Darío Golemba, Viviana Ré, Luciana Barbini, Rodolfo Campos, Spreading of hepatitis C virus subtypes 1a and 1b through the central region of Argentina, Infection, Genetics and Evolution, 2014, 26, 32

    CrossRef

  72. 72
    Chunhua Li, Manqiong Yuan, Ling Lu, Teng Lu, Wenjie Xia, Van H. Pham, An X.D. Vo, Mindie H. Nguyen, Kenji Abe, The genetic diversity and evolutionary history of hepatitis C virus in Vietnam, Virology, 2014, 468-470, 197

    CrossRef

  73. 73
    Siobhán B. Cashman, Brian D. Marsden, Lynn B. Dustin, The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development, Frontiers in Immunology, 2014, 5,

    CrossRef

  74. 74
    Marlin Benedet, Dena Adachi, Anita Wong, Sallene Wong, Kanti Pabbaraju, Raymond Tellier, Julian W. Tang, The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: A 1 year analysis, Journal of Clinical Virology, 2014, 60, 3, 301

    CrossRef

  75. 75
    Kallol Saha, Rushna Firdaus, Aritra Biswas, Anirban Mukherjee, Kamalesh Sarkar, Sekhar Chakrabarti, Provash Chandra Sadhukhan, Transmission dynamics of hepatitis C virus among intra venous drug users in the border state of Manipur, India, Infection, Genetics and Evolution, 2014, 24, 57

    CrossRef

  76. 76
    Mark Harris, Hepatitis C virus, eLS,
  77. 77
    Kurinchi Selvan Gurusamy, Douglas Thorburn, Emmanuel Tsochatzis, Brian R Davidson, Pharmacological treatments for acute hepatitis C infection: a network meta-analysis, The Cochrane Library,
  78. 78
    Kurinchi Selvan Gurusamy, Clare D Toon, Douglas Thorburn, Emmanuel Tsochatzis, Brian R Davidson, Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis, The Cochrane Library,